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Background: Cell transplantation into the damaged myocardium for regeneration has received extensive attention. The accumulated evidence 
from both pre-clinical/clinical studies suggests that it has the potential to restore heart function. Tissue engineering (TE) involves seeding a 
biodegradable scaffold with cells that grows into morphologically recognizable tissue both in vitro and in vivo. The optimal biomaterials and cell 
types, however, have not been identified.
Methods: Preliminary data obtained in our lab show that both Cardiac Stem Cells (CSCs) and Cardiospheres Derived Cells (CDC) can growth 
within and populate the type I collagen matrix in use for tissue engineering. A model of myocardial infarction has been created in mice: The left 
anterior descending (LAD) has been proximally ligated in order to create a clearly visible area of segmental myocardial ischemia. The microtissue 
was applied to the surface of the epicardium of the ischemic area and fixed with absorbable sutures. The control group underwent only LAD ligation. 
Cardiac morphology and ejection fraction (EF) have been assessed by echocardiography (Visualsonics VeVo 770/2100 echocardiographic apparatus 
designed for small animals, equipped with a 40 MHz probe).
Results: Operative mortality was 12.5%. At postoperative day 45, the group treated with the microtissue showed significantly lower end-diastolic 
volume (60.72±6.67 μl) than control group (91.52±5.59 μl). Improvements in EF were observed in the treated group (35.74±5.23). In contrast, EF 
deteriorated in the sham group (21.56±3.0). Left ventricular wall thickness values measured at the level of the infarcted areas showed a thickened 
ventricular wall in treated group. Histology showed fragments of the cellularized matrix thickening and protecting the infarct scars.
Conclusions: In infarcted mouse hearts, cell seeded matrix transpalantation prevents myocardial wall thinning and limits postischemic 
remodeling. The association of the matrix seeded with CSCs seems to be the most efficient approach to reduce postischemic ventricular dilation and 
could emerge as a new therapeutic tool for the prevention of adverse remodeling and progressive heart failure.
